Diagnostics

Anivive Receives NIAID Contract Worth Up to $33M to Progress Valley Fever VaccineAnivive Receives NIAID Contract Worth Up to $33M to Progress Valley Fever Vaccine

Anivive Receives NIAID Contract Worth Up to $33M to Progress Valley Fever Vaccine

LONG BEACH, Calif., Aug. 2, 2024 /PRNewswire/ -- Anivive Lifesciences Inc, a One Health technology company today announced that the National…

11 months ago
Immunovia files US patent application to protect its next-generation testImmunovia files US patent application to protect its next-generation test

Immunovia files US patent application to protect its next-generation test

LUND, Sweden, Aug. 2, 2024 /PRNewswire/ -- Immunovia (Nasdaq Stockholm: IMMNOV), the pancreatic cancer diagnostics company, today announces the company…

11 months ago
Hitachi High-Tech Acquires Majority Interest in NabsysHitachi High-Tech Acquires Majority Interest in Nabsys

Hitachi High-Tech Acquires Majority Interest in Nabsys

Transaction Strengthens the Molecular Research and Diagnostics Business by Providing Human Genome Analysis Solutions TOKYO and PROVIDENCE, R.I., Aug. 1,…

11 months ago
Two Investigator-Initiated Responder Analysis Trials of Jaguar Health’s Crofelemer Show Significant Positive Results for Chronic Refractory Diarrhea in IBS-D: Data Accepted for Presentation at American College of Gastroenterology 2024 Annual MeetingTwo Investigator-Initiated Responder Analysis Trials of Jaguar Health’s Crofelemer Show Significant Positive Results for Chronic Refractory Diarrhea in IBS-D: Data Accepted for Presentation at American College of Gastroenterology 2024 Annual Meeting

Two Investigator-Initiated Responder Analysis Trials of Jaguar Health’s Crofelemer Show Significant Positive Results for Chronic Refractory Diarrhea in IBS-D: Data Accepted for Presentation at American College of Gastroenterology 2024 Annual Meeting

It is estimated that 10-15% of people in the United States have IBS SAN FRANCISCO, CA / ACCESSWIRE / August…

11 months ago
Two Investigator-Initiated Responder Analysis Trials of Jaguar Health’s Crofelemer Show Significant Positive Results for Chronic Refractory Diarrhea in IBS-D: Data Accepted for Presentation at American College of Gastroenterology 2024 Annual MeetingTwo Investigator-Initiated Responder Analysis Trials of Jaguar Health’s Crofelemer Show Significant Positive Results for Chronic Refractory Diarrhea in IBS-D: Data Accepted for Presentation at American College of Gastroenterology 2024 Annual Meeting

Two Investigator-Initiated Responder Analysis Trials of Jaguar Health’s Crofelemer Show Significant Positive Results for Chronic Refractory Diarrhea in IBS-D: Data Accepted for Presentation at American College of Gastroenterology 2024 Annual Meeting

It is estimated that 10-15% of people in the United States have IBS SAN FRANCISCO, CA / ACCESSWIRE / August…

11 months ago
DiamiR Biosciences Secures EU Patent Covering the Use of microRNA Biomarkers from Bodily Fluids for Differential Diagnosis of Amyotrophic Lateral SclerosisDiamiR Biosciences Secures EU Patent Covering the Use of microRNA Biomarkers from Bodily Fluids for Differential Diagnosis of Amyotrophic Lateral Sclerosis

DiamiR Biosciences Secures EU Patent Covering the Use of microRNA Biomarkers from Bodily Fluids for Differential Diagnosis of Amyotrophic Lateral Sclerosis

NEW HAVEN, CT, and MONMOUTH JUNCTION, N.J., Aug. 01, 2024 (GLOBE NEWSWIRE) -- DiamiR, a developer of innovative blood-based diagnostic…

11 months ago
New ZEISS Study Finds Majority of Parents Worry About Impact of Screen Time on Their Children’s Eye Health, Value Protective Behaviors to Maintain EyesightNew ZEISS Study Finds Majority of Parents Worry About Impact of Screen Time on Their Children’s Eye Health, Value Protective Behaviors to Maintain Eyesight

New ZEISS Study Finds Majority of Parents Worry About Impact of Screen Time on Their Children’s Eye Health, Value Protective Behaviors to Maintain Eyesight

Amid Children’s Eye Health and Safety Month, ZEISS Recommends New SmartLife Young Lenses Designed to Meet Changing Needs of Children…

11 months ago
Laboratory Automation Systems Market size is set to grow by USD 2.01 billion from 2024-2028, Increasing demand for laboratory automation software services boost the market, TechnavioLaboratory Automation Systems Market size is set to grow by USD 2.01 billion from 2024-2028, Increasing demand for laboratory automation software services boost the market, Technavio

Laboratory Automation Systems Market size is set to grow by USD 2.01 billion from 2024-2028, Increasing demand for laboratory automation software services boost the market, Technavio

NEW YORK, July 31, 2024 /PRNewswire/ -- The global laboratory automation systems market size is estimated to grow by USD…

11 months ago
Diagnostic Wearable Medical Devices Market size is set to grow by USD 8.76 billion from 2024-2028, Increasing prevalence of chronic diseases to boost the market growth, TechnavioDiagnostic Wearable Medical Devices Market size is set to grow by USD 8.76 billion from 2024-2028, Increasing prevalence of chronic diseases to boost the market growth, Technavio

Diagnostic Wearable Medical Devices Market size is set to grow by USD 8.76 billion from 2024-2028, Increasing prevalence of chronic diseases to boost the market growth, Technavio

NEW YORK, July 31, 2024 /PRNewswire/ -- The global diagnostic wearable medical devices market size is estimated to grow by USD…

11 months ago
Digital Pathology Market size is set to grow by USD 1.12 billion from 2024-2028, Growing adoption of IoT infrastructure among laboratories boost the market, TechnavioDigital Pathology Market size is set to grow by USD 1.12 billion from 2024-2028, Growing adoption of IoT infrastructure among laboratories boost the market, Technavio

Digital Pathology Market size is set to grow by USD 1.12 billion from 2024-2028, Growing adoption of IoT infrastructure among laboratories boost the market, Technavio

NEW YORK, July 31, 2024 /PRNewswire/ -- The global digital pathology market size is estimated to grow by USD 1.12…

11 months ago
Show more Posts
Show previous Posts